Search

Your search keyword '"Jirström, Karin"' showing total 1,660 results

Search Constraints

Start Over You searched for: Author "Jirström, Karin" Remove constraint Author: "Jirström, Karin"
1,660 results on '"Jirström, Karin"'

Search Results

51. Supplementary Figure S2 from G Protein–Coupled Estrogen Receptor Is Apoptotic and Correlates with Increased Distant Disease-Free Survival of Estrogen Receptor–Positive Breast Cancer Patients

52. Supplementary Figure 3 from miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

55. Evaluation of added discriminatory ability from A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort

56. Spearman coefficients of correlation from A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort

57. Supplementary Figure Legend from miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

59. Figure S2 from BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer

60. Supplementary Methods, Figures 3-5 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma

62. Supplementary Tables 1-3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

63. Supplementary Table 4 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma

64. Supplementary Figure 3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

65. Supplementary Table 3 from miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

66. Supplemental Material from A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk

67. Supplementary Methods from miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

68. Supplementary Figure 1 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

69. Table S2 from BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer

70. Supplementary Table 1 from miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

71. Supplementary Table 3 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma

72. Supplementary Figure 2 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma

73. Supplementary Figure 2 from miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

75. Supplementary Figure 5 from miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

76. Supplementary Table 2 from miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

77. ROC curves and C-statistics by tumor stage from A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort

78. Supplementary Table 2 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma

79. Supplementary Figure 1 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma

80. Supplementary Table 1 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma

81. Supplementary Figure Legends 53 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma

82. Supplementary Figure 2 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

83. Supplementary Figure 4 from miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

84. Supplementary Table 4 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

85. C-statistics by tumor histology from A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort

86. Supplementary Figure Legends 1-3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

87. Supplementary Table S1 from G Protein–Coupled Estrogen Receptor Is Apoptotic and Correlates with Increased Distant Disease-Free Survival of Estrogen Receptor–Positive Breast Cancer Patients

88. Case characteristics from A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort

89. Supplementary Figure 1 from miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

90. Supplementary Table 4 from miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

92. Data from STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer

99. Supplementary Figure 3 from Forkhead Box F1 Regulates Tumor-Promoting Properties of Cancer-Associated Fibroblasts in Lung Cancer

100. Supplementary Figure 3 from STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer

Catalog

Books, media, physical & digital resources